Eating Disorders Trial, Recruiting NCT06759402 Sponsor: Charite University, Berlin, Germany Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT06759402
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with anorexia nervosa (either the restrictive type or the binge-purge type)
  • Your doctor has determined that you need inpatient (hospital-based) treatment, based on current medical guidelines
  • Your weight is below the 3rd percentile for your age and height (meaning very significantly underweight compared to others your age), OR
  • Your weight is below the 10th percentile AND you also have an additional mental health condition, are losing weight quickly, or have not gained weight during outpatient treatment over the last three months
  • You are planning to receive inpatient treatment
  • You are insured with one of the health insurance companies participating in this trial
  • You have a reliable internet connection at home

Who may not be able to join:

  • Your weight has dropped below 67% of the expected healthy body weight for your age and height (severely underweight — confirm with trial site)
  • You are currently harming yourself or are considered a danger to others
  • You are currently experiencing psychosis (losing touch with reality) or have active thoughts of suicide
  • You are currently misusing alcohol or drugs
  • There is ongoing child abuse or domestic violence in your household
  • You are insured with a health insurance company that is not part of this trial
  • Your inpatient treatment has been ordered by a court
  • There are known, current child protection concerns or active family court proceedings involving your family

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christoph U Correll, MD, Charite University, Berlin, Germany

Phone: +4930 450 566 399

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 January 2025
Est. completion
31 March 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Change in %mBMI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov